Bellevue Life Sciences Acquisition Corp. (BLAC) Research

Bellevue Life Sciences Acquisition Corp. currently does not engage in substantial operational activities. Its core mission is to orchestrate a business combination, which could manifest as a merger, share exchange, asset acquisition, stock purchase, recapitalization, or reorganization, with one or more enterprises or organizations within the healthcare domain. This firm, established in 2020, maintains its principal office in Bellevue, Washington, and operates as a subordinate entity of Bellevue Global Life Sciences Investors LLC.

Market snapshot

Symbol
BLAC
Price
$3.01
Day change
-55.27%
Market cap
$9.6M
P/E ratio
-0.13x
52-week range
3.01-13.4
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • ATIF Holdings Ltd. (ATIF)
  • Bannix Acquisition Corp. (BNIX)
  • Brilliant Acquisition Corporation (BRLI)
  • Cetus Capital Acquisition Corp. (CETU)
  • EON Resources Inc. (EONR)
  • JV SPAC Acquisition Corp. Class A Ordinary Share (JVSA)
  • RF Acquisition Corp. (RFAC)
  • Safeguard Scientifics, Inc. (SFES)

Open Bellevue Life Sciences Acquisition Corp. (BLAC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.